Notice2024-06011

Center for Scientific Review; Notice of Closed Meetings

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
March 21, 2024

Issuing agencies

Health and Human Services DepartmentNational Institutes of Health

Full Text

<html>
<head>
<title>Federal Register, Volume 89 Issue 56 (Thursday, March 21, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 56 (Thursday, March 21, 2024)]
[Notices]
[Page 20224]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-06011]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Vascular Biology and Pathophysiology.
    Date: April 12, 2024.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Vivian Tang, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Bethesda, MD 20892, (301) 594-6208, 
<a href="/cdn-cgi/l/email-protection#eb9f8a858c9d9cab889899c5858283c58c849d"><span class="__cf_email__" data-cfemail="4034212e273637002333326e2e29286e272f36">[email&#160;protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR-22-233: Time-Sensitive Opportunities for Health Research.
    Date: April 12, 2024.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Wenjuan Wang, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institute of Health, 6701 
Rockledge Drive, Room 3154, Bethesda, MD 20892, (301) 480-8667, 
<a href="/cdn-cgi/l/email-protection#2255434c45551010624f434b4e0c4c4b4a0c454d54"><span class="__cf_email__" data-cfemail="0b7c6a656c7c39394b666a626725656263256c647d">[email&#160;protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Cancer Biology.
    Date: April 12, 2024.
    Time: 12:00 p.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Amy L. Rubinstein, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5152, MSC 7844, Bethesda, MD 
20892, 301-408-9754, <a href="/cdn-cgi/l/email-protection#90e2e5f2f9fee3e4f5f9fef1fcd0f3e3e2befef9f8bef7ffe6"><span class="__cf_email__" data-cfemail="abd9dec9c2c5d8dfcec2c5cac7ebc8d8d985c5c2c385ccc4dd">[email&#160;protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; RFA: Public Health Communication Messaging about the 
Continuum of Risk for Tobacco Products.
    Date: April 15, 2024.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Pamela Jeter, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institute of Health, 6701 
Rockledge Drive, Room 10J08, Bethesda, MD 20892, (301) 827-6401, 
<a href="/cdn-cgi/l/email-protection#8efeefe3ebe2efa0e4ebfaebfccee0e7e6a0e9e1f8"><span class="__cf_email__" data-cfemail="e797868a828b86c98d82938295a7898e8fc9808891">[email&#160;protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Topics in Basic Cancer Immunology.
    Date: April 17, 2024.
    Time: 10:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Sarita Kandula Sastry, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20782, 301-402-4788, 
<a href="/cdn-cgi/l/email-protection#e89b899a819c89c69b899b9c9a91a8868180c68f879e"><span class="__cf_email__" data-cfemail="ddaebcafb4a9bcf3aebcaea9afa49db3b4b5f3bab2ab">[email&#160;protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: March 18, 2024.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-06011 Filed 3-20-24; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on March 21, 2024.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.